Open Access Mini Review

Proton Pump Inhibitors for Laryngopharyngeal Reflux: What Do We Know?

Christine M Carmichael*

Woolfolk School of Communication Sciences and Disorders, Our Lady of the Lake University, United States

Corresponding Author

Received Date: December 17, 2019;  Published Date: December 19, 2019

Abstract

Proton pump inhibitors have been used for the last three decades to treat reflux and other gastric disorders. Although originally FDA approved and presumed safe, reports of serious health conditions linked to long-term use are surfacing. The FDA has since issued several announcements regarding safety of proton pump inhibitors. Specific health risks are reviewed, and alternative treatments presented.

Keywords: Laryngopharyngeal reflux; Proton pump inhibitor; Safety

Abbreviations: PPI: Proton pump inhibitor; FDA: Food and drug administration; OTC: Over the counter; GERD: Gastroesophageal reflux disease; LPR: Laryngopharyngeal reflux; BID: Bis in die [twice a day]; ANC: Antacid neutralizing capacity; PRN: Pro re nata [as needed]

Citation
Signup for Newsletter
Scroll to Top